These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9123416)

  • 1. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 2. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

  • 3. Cadaveric renal transplantation at University Hospital Kuala Lumpur: a preliminary report.
    Tan SY; Chen TP; Lee SH; Tan PS; Chua CT; Teo SM; Thiruventhiran T; Wo M; Loh CS; Hassan A; Tan JC; Koh SN
    Transplant Proc; 2000 Nov; 32(7):1811-2. PubMed ID: 11119947
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of delayed graft function on cadaveric kidney transplant outcome.
    Gentil MA; Alcaide MP; Algarra GR; Pereira P; Toro J; González-Roncero F; López M; Bernal G; Mateos J
    Transplant Proc; 2003 Mar; 35(2):689-91. PubMed ID: 12644095
    [No Abstract]   [Full Text] [Related]  

  • 5. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 6. Allograft instability with frequent acute rejections and early chronic transplant glomerulopathy related to suboptimal doses of cyclosporine A.
    Savin M; Petronic V; Djukanovic L; Dujic A; Stojkovic D; Sindjic M
    Transplant Proc; 1997 Nov; 29(7):2977-9. PubMed ID: 9365636
    [No Abstract]   [Full Text] [Related]  

  • 7. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
    Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract]   [Full Text] [Related]  

  • 9. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

  • 10. Etiology of early renal allograft dysfunction after live donor renal transplantation.
    Morrissey PE; Gohh R; Madras PN; Shaffer D; Davis C; Conway P; Sahyoun A; Monaco AP
    Transplant Proc; 1998 Jun; 30(4):1320. PubMed ID: 9636536
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
    Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
    Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of acute rejection episodes on long-term renal graft survival.
    Berczi C; Asztalos L; Kincses Z; Löcsey L; Balázs G
    Transplant Proc; 1998 Aug; 30(5):1775. PubMed ID: 9723277
    [No Abstract]   [Full Text] [Related]  

  • 14. Kidney transplantation from living related donors.
    Mouquet C; Benalia H; Barrou B; Ourahma S; Luciani J; Coriat P; Bitker MO
    Transplant Proc; 1996 Oct; 28(5):2801. PubMed ID: 8908065
    [No Abstract]   [Full Text] [Related]  

  • 15. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus-based immunosuppression in pediatric renal transplantation.
    Jordan ML; Shapiro R; Scantlebury V; Vivas C; Ellis D; Lombardozzi-Lane S; Starzl TE
    Transplant Proc; 1999 Nov; 31(7A):29S-30S. PubMed ID: 10576039
    [No Abstract]   [Full Text] [Related]  

  • 19. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extreme donor age on the outcome of living-related donor kidney transplantation.
    Uslu A; Tokat Y; Ok E; Unsal A; Celik A; Yalaz S; Kaplan H
    Transplant Proc; 1998 May; 30(3):734-7. PubMed ID: 9595078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.